NR2F2 alleviates pulmonary fibrosis by inhibition of epithelial cell senescence

Respir Res. 2024 Apr 2;25(1):154. doi: 10.1186/s12931-024-02777-3.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fatal, and aging-associated interstitial lung disease with a poor prognosis and limited treatment options, while the pathogenesis remains elusive. In this study, we found that the expression of nuclear receptor subfamily 2 group F member 2 (NR2F2), a member of the steroid thyroid hormone superfamily of nuclear receptors, was reduced in both IPF and bleomycin-induced fibrotic lungs, markedly in bleomycin-induced senescent epithelial cells. Inhibition of NR2F2 expression increased the expression of senescence markers such as p21 and p16 in lung epithelial cells, and activated fibroblasts through epithelial-mesenchymal crosstalk, inversely overexpression of NR2F2 alleviated bleomycin-induced epithelial cell senescence and inhibited fibroblast activation. Subsequent mechanistic studies revealed that overexpression of NR2F2 alleviated DNA damage in lung epithelial cells and inhibited cell senescence. Adenovirus-mediated Nr2f2 overexpression attenuated bleomycin-induced lung fibrosis and cell senescence in mice. In summary, these data demonstrate that NR2F2 is involved in lung epithelial cell senescence, and targeting NR2F2 may be a promising therapeutic approach against lung cell senescence and fibrosis.

Keywords: Cell senescence; DNA damage; Epithelial-mesenchymal crosstalk; NR2F2; Pulmonary fibrosis.

MeSH terms

  • Animals
  • Bleomycin / adverse effects
  • Cellular Senescence*
  • Epithelial Cells / metabolism
  • Idiopathic Pulmonary Fibrosis* / drug therapy
  • Lung / metabolism
  • Mice

Substances

  • Bleomycin
  • Nr2f2 protein, mouse